“cancer” Archives

in
Entry Author Date Location
Kyn Nabs $49M to Target Metabolism and Beat Other Cancer Drug Combos 12/14/17 Boston
Andreessen Horowitz Floats Second Bio Fund with $450M 12/14/17 San Francisco
Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan 12/13/17 Texas
Lilly Nixes Expansion of Stomach Cancer Drug After Mixed Study Results 12/11/17 Indiana
Gilead Bets on Cell Therapy Again with $567M Cell Design Labs Deal 12/07/17 San Francisco
Will Foundation’s FDA, CMS Nod Help Cancer DNA Tests Break Through? 12/01/17 Boston
Chemo Tops Pfizer, Merck KGaA Drug in Big Stomach Cancer Test 11/28/17 New York
Lacking Details, Roche Touts Drug Combo’s Success in Lung Cancer 11/20/17 San Francisco
Xconomy Peers into Biotech Future with Vividion’s Diego Miralles 11/16/17 San Diego
X4 Pharma Pulls In $27M for Immune Drug in Cancer, Rare Diseases 11/16/17 Boston
With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer 11/14/17 Boston
Juno Dissects ROCKET Deaths, Will Aim Better CAR-T at Leukemia 11/10/17 Seattle
OncoResponse Buys Paganini Biopharma to Add Cancer Drug to Pipeline 11/08/17 Texas
Five Prime Shares Dive on Latest Hiccup For Cancer Immunotherapy Combos 11/07/17 San Francisco
Q&A: Xconomy Award Winner Nikhil Wagle on Building Patient Partnerships 10/30/17 Boston
Tocagen Adopts “Seamless Pivotal Trial” for Brain Cancer Therapy 10/27/17 San Diego
Terminated Blood Cancer Drug Springs Back to Life at SD Biotech 10/26/17 San Diego
Clinical Trial Lab Intrinsic Imaging Joins Rise of AI in Radiology 10/20/17 Texas
Kite Nabs First Adult CAR-T Approval With Notable Uptick Of Cures 10/18/17 National
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact 10/18/17 Indiana
From UCSF, New Sequencer Reveals Cancer Blueprints, Cell By Cell 10/17/17 San Francisco
Bridge Project Q&A: “Big Idea” Winners on Connecting Cancer Experts 10/16/17 Boston
Eli Lilly Drug Fails in Lung Cancer, Stalling Oncology Strategy 10/10/17 Indiana
Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug 10/04/17 Boston
Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal 10/02/17 Indiana
Five Questions For … Austin Biotech Entrepreneur Paul Lammers 09/29/17 Texas
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
Deciphera IPO Drums Up $128M for Cancer Drug Studies 09/28/17 Boston
San Antonio Spends $200,000 to Get New Biotech Pelican Therapeutics 09/25/17 Texas
Halozyme Inks $105M Bristol-Myers Partnership, Expands Roche Deal 09/14/17 San Diego
Page 1 of 69 next page »